[1] Ruggenenti P, Remuzzi G. Time to abandon micro-albuminuria[J] . Kidney Int,2006,70(7): 1214-1222.
[2] KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease[J] . Am J Kidney Dis,2007,49(2 Suppl 2): S12-S154.
[3] Miller WG,Bruns DE,Hortin GL,et al. Current issues in measurement and reporting of urinary albumin excretion[J] . Clin Chem,2009,55(1): 24-38.
[4] Osicka TM,Comper WD. Characterization of immuno-chemically nonreactive urinary albumin[J] . Clin Chem,2004,50(12):2286-2291.
[5] Greive KA,Eppel GA,Reeve S,et al. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats[J] . Am J Kidney Dis,2001,38(1):144-152.
[6] Comper WD,Osicka TM,Jerums G. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients[J] . Am J Kidney Dis,2003,41(2):336-342.
[7] Gunasekara D,Byrnes L,Brown S,et al. Clinical implications of the early detection of urinary microalbumin in diabetic patients using a new high performance liquid chromatography (HPLC) method[J] . Diabetes Res Clin Pract,2011,93(2):e61-e64. |